Dural metastasis causing seizures after treatment for signet-ring gastric cancer

Patient Info: Anonymized, female, Under 40 | Stage IV

Metastatic Site: dura mater

She died 16 days after hospital admission for neurologic symptoms, roughly 8 months after the original gastric-cancer diagnosis, following rapid deterioration from diffuse dural metastatic disease.

PubMed CentralRead more →

Stage II Breast Cancer: Marese's Survivor Story

Patient Info: Marese | Stage II

Marese said the breast cancer was in remission after completing active treatment, and she continued hormone therapy to help maintain remission.

Our Cancer StoriesRead more →

Device Closure of a Persistent Air Leak After Lung Cancer Surgery

Patient Info: Anonymized, Female, 60s

Thoracoscopic exploration found no recurrent cancer, and the fistula remained successfully closed with the patient asymptomatic at 12 months.

PubMed CentralRead more →

Stage II Breast Cancer: Emma's Patient Story

Patient Info: Emma, Female, 40s | Stage II

As of 2019, Emma had completed active treatment for Stage II breast cancer after mastectomy, lymphadenectomy, chemotherapy, and hormone therapy, and she remained on hormone therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Kathryn's Survivor Story

Patient Info: Kathryn | Stage III

After completing treatment, Kathryn said she had successfully beaten the cancer and was focused on enjoying life and making memories with loved ones.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Aura's Patient Story

Patient Info: Aura, Female, 40s | Stage I

Aura completed mastectomy, lymphadenectomy, hysterectomy, and chemotherapy for Stage I breast cancer and remained on hormone therapy, with ongoing concerns but no documented recurrence or progression.

Our Cancer StoriesRead more →

Gastric cancer surgery leads to the diagnosis of previously unrecognized Gaucher disease

Patient Info: Anonymized, Female, 60s

A 69-year-old woman underwent surgery for gastric adenocarcinoma, while unusual bone-marrow and lymph-node findings led to a separate diagnosis of Gaucher disease.

PubMed CentralRead more →

A small Grade 1 gastric neuroendocrine tumor treated with local laparoscopic resection after sentinel-node assessment

Patient Info: Anonymized, Female, 60s

Biomarkers: Ki-67 <2%

She was alive without disease recurrence 16 months after surgery.

PubMed CentralRead more →

Gastric stump adenocarcinoma develops more than 20 years after partial gastrectomy for peptic ulcer

Patient Info: Anonymized, Male, 50s

He died 10 months after surgery.

PubMed CentralRead more →

Synchronous Stage IA breast cancer and Stage IIA lung adenocarcinoma: disease-free after surgery and adjuvant therapy

Patient Info: Anonymized, Female, 60s | Stage I

Biomarkers: Breast tumor: ER/PR positive, HER2 negative. Lung tumor: KRAS/EGFR wild type, ALK rearrangement not detected.

As of April 2014, more than 2 years of follow-up showed no recurrent disease after treatment of synchronous Stage IA breast cancer and Stage IIA lung adenocarcinoma.

PubMed CentralRead more →

Metastatic lobular breast cancer to gynecologic sites: disease-free after surgery and chemotherapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-negative; HER2/C-Erb-B2-negative

Metastatic Site: vagina, uterus, ovaries

After treatment of vaginal, uterine, and ovarian metastases from lobular breast cancer, she was free from disease 12 months after completion surgery.

PubMed CentralRead more →

Sigmoid colon cancer with later inguinal lymph-node metastasis: surgery, FOLFOX, FOLFIRI, and cetuximab

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: CEA was elevated at diagnosis and recurrence. Metastatic lymph node was CK20 positive/CK7 negative; EGFR mutation status not reported.

Metastatic Site: left inguinal lymph node

Apparently disease-free 8 months after surgical removal of the left inguinal lymph-node metastasis followed by FOLFIRI plus cetuximab.

PubMed CentralRead more →

Stage I BRCA1 Breast Cancer: Karen's Patient Story

Patient Info: Karen | Stage I

Biomarkers: BRCA1 mutation

Karen completed surgery and chemotherapy for stage 1 breast cancer and chose prophylactic bilateral mastectomy because of a BRCA1 mutation, while continuing to live with fear of recurrence.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Mary's Survivor Story

Patient Info: Mary | Stage III

Mary said she was in remission and no longer required cancer treatment.

Our Cancer StoriesRead more →